The Boston Bar Association will host its first Life Sciences Conference, featuring panels that will explore the interplay between the life sciences sector and the law. The goal of this conference is to provide a unique educational opportunity for all life sciences practitioners to exchange ideas and learn about new perspectives. CRA is sponsoring this conference.
For more information, click here.
Pricing implications for drugs included in China’s Rare Diseases Catalogue (RDC)
China’s Rare Disease Catalogue (RDC) plays a growing role in shaping awareness, investment, and access to therapies for rare diseases in China.